 Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 4 | 4 | | 1984 | 0 | 12 | 12 | | 1985 | 0 | 13 | 13 | | 1986 | 0 | 13 | 13 | | 1987 | 0 | 13 | 13 | | 1988 | 0 | 11 | 11 | | 1989 | 0 | 18 | 18 | | 1990 | 0 | 20 | 20 | | 1991 | 0 | 9 | 9 | | 1992 | 0 | 15 | 15 | | 1993 | 0 | 28 | 28 | | 1994 | 0 | 24 | 24 | | 1995 | 0 | 36 | 36 | | 1996 | 0 | 18 | 18 | | 1997 | 0 | 19 | 19 | | 1998 | 0 | 28 | 28 | | 1999 | 0 | 32 | 32 | | 2000 | 0 | 24 | 24 | | 2001 | 1 | 33 | 34 | | 2002 | 0 | 25 | 25 | | 2003 | 0 | 37 | 37 | | 2004 | 1 | 41 | 42 | | 2005 | 2 | 32 | 34 | | 2006 | 1 | 25 | 26 | | 2007 | 1 | 41 | 42 | | 2008 | 1 | 46 | 47 | | 2009 | 1 | 46 | 47 | | 2010 | 0 | 50 | 50 | | 2011 | 0 | 44 | 44 | | 2012 | 0 | 32 | 32 | | 2013 | 0 | 30 | 30 | | 2014 | 1 | 35 | 36 | | 2015 | 1 | 26 | 27 | | 2016 | 0 | 42 | 42 | | 2017 | 0 | 39 | 39 | | 2018 | 1 | 35 | 36 | | 2019 | 1 | 42 | 43 | | 2020 | 0 | 13 | 13 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Mendelson SJ, Prabhakaran S. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021 Mar 16; 325(11):1088-1098.
-
Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program. JAMA. 2020 12 08; 324(22):2301-2317.
-
Rosenberg AJ. Multimodality Therapy for Locoregional Nasopharyngeal Carcinoma-A Decision Tool for Treatment Optimization. JAMA Netw Open. 2020 12 01; 3(12):e2030672.
-
Gutiontov SI, Pitroda SP, Chmura SJ, Arina A, Weichselbaum RR. Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):17-26.
-
Voorhees PM, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Costa LJ, Anderson LD, Nathwani N, Shah N, Efebera YA, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Murphy S, Lutska Y, Pei H, Ukropec J, Vermeulen J, de Boer C, Hoehn D, Lin TS, Richardson PG. Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial. Blood. 2020 08 20; 136(8):936-945.
-
Cassaday RD, Marks DI, DeAngelo DJ, Jabbour EJ, Advani AS, O'Brien S, Wang T, Neuhof A, Vandendries E, Kantarjian HM, Stock W, Stelljes M. Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin. Br J Haematol. 2020 11; 191(3):e77-e81.
-
Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, Dinakar C, Ellis AK, Finegold I, Golden DBK, Greenhawt MJ, Hagan JB, Horner CC, Khan DA, Lang DM, Larenas-Linnemann DES, Lieberman JA, Meltzer EO, Oppenheimer JJ, Rank MA, Shaker MS, Shaw JL, Steven GC, Stukus DR, Wang J. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020 10; 146(4):721-767.
-
Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, Willett C, Stiles B, Sharma P, Tang L, Wijnhoven BPL, Hofstetter WL. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2020 08 10; 38(23):2677-2694.
-
Korpics MC, Polley MY, Bhave SR, Redler G, Pitroda SP, Luke JJ, Chmura SJ. A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):189-195.
-
Schultz K, Wolf JM. Digital Ischemia in COVID-19 Patients: Case Report. J Hand Surg Am. 2020 06; 45(6):518-522.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|